B+L completes Technolas acquisition

Article

Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.

Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.

The new collaboration will be known as Bausch + Lomb Technolas and will continue developing and commercializing surgical laser technology for ophthalmology.

B+L purchased all outstanding shares of Technolas in November 2012 to expand the company's product portfolio into cataract and refractive surgery. The companies have been co-promoting the Victus femtosecond laser, which received marketing approval in Europe in late 2011. Technolas is also developing the Supracor for the treatment of presbyopia.

John Barr, executive president of B+L, commented, "Technolas Perfect Vision’s unique laser platforms will enhance our ability to grow the business and augment our new product pipeline with cutting-edge surgical technology. We are pleased to welcome the Technolas Perfect Vision team to Bausch + Lomb and are committed to a seamless transition as we continue to provide physicians with systems, instruments and intraocular lenses that improve patients’ sight worldwide."

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.